337 related articles for article (PubMed ID: 30448597)
1. Serum Concentrations of 7α-hydroxy-4-cholesten-3-one Are Associated With Bile Acid Diarrhea in Patients With Crohn's Disease.
Battat R; Duijvestein M; Vande Casteele N; Singh S; Dulai PS; Valasek MA; Mimms L; McFarland J; Hester KD; Renshaw M; Jain A; Sandborn WJ; Boland BS
Clin Gastroenterol Hepatol; 2019 Dec; 17(13):2722-2730.e4. PubMed ID: 30448597
[TBL] [Abstract][Full Text] [Related]
2. Serum 7-alfa-hydroxy-4-cholesten-3-one and fibroblast growth factor-19 as biomarkers diagnosing bile acid malabsorption in microscopic colitis and inflammatory bowel disease.
Lyutakov I; Lozanov V; Sugareva P; Valkov H; Penchev P
Eur J Gastroenterol Hepatol; 2021 Mar; 33(3):380-387. PubMed ID: 33177381
[TBL] [Abstract][Full Text] [Related]
3. Bile acid malabsorption assessed by 7 alpha-hydroxy-4-cholesten-3-one in pediatric inflammatory bowel disease: correlation to clinical and laboratory findings.
Gothe F; Beigel F; Rust C; Hajji M; Koletzko S; Freudenberg F
J Crohns Colitis; 2014 Sep; 8(9):1072-8. PubMed ID: 24666974
[TBL] [Abstract][Full Text] [Related]
4. Biochemical Diagnosis of Bile Acid Diarrhea: Prospective Comparison With the 75Seleno-Taurohomocholic Acid Test.
Borup C; Wildt S; Rumessen J; Graff J; Bouchelouche PN; Andersen TB; Vinter-Jensen L; Zaremba A; German Jørgensen SP; Gregersen T; Nøjgaard C; Timm HB; Rainteau D; Gauliard E; Munck LK
Am J Gastroenterol; 2020 Dec; 115(12):2086-2094. PubMed ID: 32740083
[TBL] [Abstract][Full Text] [Related]
5. A new mechanism for bile acid diarrhea: defective feedback inhibition of bile acid biosynthesis.
Walters JR; Tasleem AM; Omer OS; Brydon WG; Dew T; le Roux CW
Clin Gastroenterol Hepatol; 2009 Nov; 7(11):1189-94. PubMed ID: 19426836
[TBL] [Abstract][Full Text] [Related]
6. Bile acid malabsorption in inflammatory bowel disease: assessment by serum markers.
Lenicek M; Duricova D; Komarek V; Gabrysova B; Lukas M; Smerhovsky Z; Vitek L
Inflamm Bowel Dis; 2011 Jun; 17(6):1322-7. PubMed ID: 21058331
[TBL] [Abstract][Full Text] [Related]
7. Diarrhea in Crohn’s disease: investigating the role of the ileal hormone fibroblast growth factor 19.
Nolan JD; Johnston IM; Pattni SS; Dew T; Orchard TR; Walters JR
J Crohns Colitis; 2015 Feb; 9(2):125-31. PubMed ID: 25518063
[TBL] [Abstract][Full Text] [Related]
8. Non-alcoholic fatty liver disease is associated with dysregulated bile acid synthesis and diarrhea: A prospective observational study.
Appleby RN; Moghul I; Khan S; Yee M; Manousou P; Neal TD; Walters JRF
PLoS One; 2019; 14(1):e0211348. PubMed ID: 30682184
[TBL] [Abstract][Full Text] [Related]
9. Bile acid malabsorption deactivates pregnane X receptor in patients with Crohn's disease.
Iwamoto J; Saito Y; Honda A; Miyazaki T; Ikegami T; Matsuzaki Y
Inflamm Bowel Dis; 2013 May; 19(6):1278-84. PubMed ID: 23574760
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of Serum and Distal Ileum Fibroblast Growth Factor19 in Bile Acid Diarrhoea Patients.
Chang C; Jiang J; Sun R; Wang S; Chen H
Dig Dis Sci; 2022 Mar; 67(3):872-879. PubMed ID: 34041651
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast Growth Factor 19 and 7α-Hydroxy-4-Cholesten-3-one in the Diagnosis of Patients With Possible Bile Acid Diarrhea.
Pattni SS; Brydon WG; Dew T; Walters JR
Clin Transl Gastroenterol; 2012 Jul; 3(7):e18. PubMed ID: 23238290
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast growth factor 19 in patients with bile acid diarrhoea: a prospective comparison of FGF19 serum assay and SeHCAT retention.
Pattni SS; Brydon WG; Dew T; Johnston IM; Nolan JD; Srinivas M; Basumani P; Bardhan KD; Walters JR
Aliment Pharmacol Ther; 2013 Oct; 38(8):967-76. PubMed ID: 23981126
[TBL] [Abstract][Full Text] [Related]
13. Increased bile acid biosynthesis is associated with irritable bowel syndrome with diarrhea.
Wong BS; Camilleri M; Carlson P; McKinzie S; Busciglio I; Bondar O; Dyer RB; Lamsam J; Zinsmeister AR
Clin Gastroenterol Hepatol; 2012 Sep; 10(9):1009-15.e3. PubMed ID: 22610000
[TBL] [Abstract][Full Text] [Related]
14. Serum fibroblast growth factor 19 level correlates inversely with clinical and endoscopic activity of inflammatory bowel disease.
Łukawska A; Mulak A
Adv Clin Exp Med; 2024 Mar; ():. PubMed ID: 38530319
[TBL] [Abstract][Full Text] [Related]
15. Bile acid malabsorption as a cause of chronic diarrhea: diagnostic value of 7alpha-hydroxy-4-cholesten-3-one in serum.
Sauter GH; Münzing W; von Ritter C; Paumgartner G
Dig Dis Sci; 1999 Jan; 44(1):14-9. PubMed ID: 9952217
[TBL] [Abstract][Full Text] [Related]
16. Performance characteristics of serum C4 and FGF19 measurements to exclude the diagnosis of bile acid diarrhoea in IBS-diarrhoea and functional diarrhoea.
Vijayvargiya P; Camilleri M; Carlson P; Lueke A; O'Neill J; Burton D; Busciglio I; Donato L
Aliment Pharmacol Ther; 2017 Sep; 46(6):581-588. PubMed ID: 28691284
[TBL] [Abstract][Full Text] [Related]
17. Chenodeoxycholic acid stimulated fibroblast growth factor 19 response - a potential biochemical test for bile acid diarrhoea.
Borup C; Wildt S; Rumessen JJ; Bouchelouche PN; Graff J; Damgaard M; McQuitty C; Rainteau D; Munck LK
Aliment Pharmacol Ther; 2017 Jun; 45(11):1433-1442. PubMed ID: 28378364
[TBL] [Abstract][Full Text] [Related]
18. Defining primary bile acid diarrhea: making the diagnosis and recognizing the disorder.
Walters JR
Expert Rev Gastroenterol Hepatol; 2010 Oct; 4(5):561-7. PubMed ID: 20932141
[TBL] [Abstract][Full Text] [Related]
19. Response of fibroblast growth factor 19 and bile acid synthesis after a body weight-adjusted oral fat tolerance test in overweight and obese NAFLD patients: a non-randomized controlled pilot trial.
Friedrich D; Marschall HU; Lammert F
BMC Gastroenterol; 2018 Jun; 18(1):76. PubMed ID: 29866129
[TBL] [Abstract][Full Text] [Related]
20. Measurement of serum 7alpha-hydroxy-4-cholesten-3-one (or 7alphaC4), a surrogate test for bile acid malabsorption in health, ileal disease and irritable bowel syndrome using liquid chromatography-tandem mass spectrometry.
Camilleri M; Nadeau A; Tremaine WJ; Lamsam J; Burton D; Odunsi S; Sweetser S; Singh R
Neurogastroenterol Motil; 2009 Jul; 21(7):734-e43. PubMed ID: 19368662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
